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Background: It is known that obesity [measured with body mass index (BMI)] relates to
brain structure and markers of cerebral small vessel disease (CSVD). However, BMI may
not adequately represent body composition. Furthermore, whether those cross-sectional
associations hold longitudinally remains uncertain.
Methods: Three thousand six hundred and fourty-eight participants underwent baseline
(2006–2014) dual-energy X-ray absorptiometry (DXA)-scan to obtain detailed measures
of body composition and a magnetic resonance imaging (MRI) scan to assess brain
structure. One thousand eight hundred and fourty-four participants underwent a
second MRI-scan at follow-up (2010–2017; median follow-up: 5.5 years). To assess
cross-sectional and longitudinal associations (measures of change have been calculated)
between body composition [BMI, fat mass index (FMI), fat-free mass index (FFMI)],
and brain tissue volume (gray matter, white matter, hippocampus), white matter
microstructure [fractional anisotropy (FA), mean diffusivity (MD)], and CSVD markers
(white matter hyperintensity volume, lacunes, microbleeds) we used multivariable linear
and logistic regression models.
Results: A higher BMI and FMI were cross-sectionally associated with smaller white
matter volumes (difference in Z-score per SD higher BMI: −0.064 [95% CI: −0.094,
−0.035]) and FMI: −0.067 [95% CI: −0.099, −0.034], higher FA and MD. A higher
FFMI was associated larger gray matter volume (difference: 0.060 [95% CI: 0.018,
0.101]). There was no statistically significant or clinically relevant association between
body composition and brain changes.
Conclusions: Body composition, distinguishing between fat mass and fat-free mass,
does not directly influence changes in brain tissue volume, white matter integrity and
markers of CSVD. Cross-sectional associations between body composition and brain
tissue volume likely reflect cumulative risk or shared etiology.
Keywords: body composition, brain volume, white matter integrity, cerebral small vessel disease (CSVD), fat mass
index (FMI), fat-free mass index (FFMI)
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INTRODUCTION
The increasing prevalence of obesity is accompanied by
numerous adverse health effects, including cognitive decline and
dementia (1, 2). Moreover, obesity has been linked with smaller
brain tissue volumes, and decreased white matter integrity (2–5).
On top of that, it has been found that obesity is associated with
focal brain pathology in the form of cerebral small vessel disease
(CSVD) (6).
An important limitation of previous studies is that obesity
is generally assessed by body mass index (BMI) (2). However,
aging is associated with a decrease in lean mass and an increase
in fat mass, making BMI less suitable as an approximation of
obesity in the elderly (2, 7). In a study looking at the association
between body composition and metabolic syndrome the same
“BMI problem” was encountered. Researchers found that fat
mass index (FMI) was independently and positively associated
with the presence of metabolic syndrome regardless of BMI
and concluded that FMI is a better approximation of body
composition (8). A second limitation is that previous studies
mainly assessed cross-sectional relations, precluding inference
on directionality.
We studied the association of body composition, divided into
body mass, fat mass, and fat-free mass, with brain tissue volume,
white matter integrity and markers of CSVD (white matter lesion
hyperintensities (WMH), lacunes, and microbleeds) to evaluate
whether fat mass and fat-free mass is a better approximation of
body composition. Moreover, we aimed to assess the longitudinal
association between body composition and brain health.
MATERIALS AND METHODS
Setting
This study was embedded within the population-based
Rotterdam Study. At study entry and subsequently every
3–4 years, all participants were invited to undergo extensive
examinations. For the present study, 4,104 participants
(2006–2014) underwent body composition assessment with
a dual-energy X-ray absorptiometry (DXA) scan and a brain
magnetic resonance imaging (MRI) scan (9). From this group
we excluded participants with cortical infarcts on MRI (N =
164), cancer (N = 263), and dementia (N = 29), leaving 3,648
participants for the cross-sectional analyses. Between 2010 and
2017 in a subsequent examination-round, 1,844 participants had
a follow-up MRI-scan available for the longitudinal analysis.
Reasons of dropout at follow-up or unavailability of follow up
MRI information have been included in Supplemental Figure 1.
The Rotterdam Study has received medical ethical approval
according to the Population Screening Act: Rotterdam Study,
executed by the Ministry of Health, Welfare, and Sports of the
Netherlands. All participants provided written informed consent.
Body Composition
Body weight and length were measured and BMI was calculated
(kg/m2) (9). A DXA—scan (iDXA, GE Lunar Healthcare, USA)
was performed to determine fat-free mass and fat mass in
kilograms (9). From this, we calculated fat mass index (FMI)
(kg/m2), and fat-free mass index (FFMI) (kg/m2).
Brain Tissue Volume, White Matter
Integrity, and Markers of CSVD
Brain-MRI was performed on a 1.5-tesla MRI scanner with
a 8-channel head coil, using a standardized scan protocol
which has been described in detail before (9, 10). To quantify
brain tissue volume, gray matter volume, white matter volume,
WMH volume, and intracranial volume, automated brain tissue
classification was used. This quantification strategy was based on
a k-nearest neighbor classifier algorithm, extended with an in-
house-developed WMH segmentation (10). Total brain volume
did not include the cerebellum (used MRI segmentation only
segments supratentorial brain tissue and not all MRI scans
incorporated the entire cerebellum in the field of view). T1-
weighted MR images were processed using FreeSurfer (version
5.1) to obtain the hippocampus volume (9). White matter
microstructure [fractional anisotropy (FA), mean diffusivity
(MD)] was assessed with diffusion weighted imaging (9, 11).
Visual ratings were performed for presence of lacunes or
microbleeds (9).
Covariables
Information on energy intake, smoking, alcohol, education,
and physical activity was obtained from questionnaires and
interviews as described in detail in the supplement (9).
Statistics
We investigated associations of body composition with brain
tissue volumes, WMH volume (log-transformed), and FA and
MD as a ratio of intracranial volume (to adjust for absolute head
size differences) using linear regression models. We calculated
changes by subtracting baseline measurement from follow-up
measurement, which were eventually standardized and used to
assess the longitudinal association with linear regression models.
The association of body composition with presence of lacunes
and microbleeds at baseline and the progression of lacunes
or microbleeds at follow-up for the longitudinal analysis was
assessed with logistic regression models. Adjustments were made
for age, age2, sex, and education (model 1). We additionally
adjusted for energy intake, smoking, physical activity, and alcohol
(model 2). Adding height, hypertension, hypercholesterolemia,
and diabetes to the regression models did not change the effect
estimates and were therefore left out of the final analysis. For the
longitudinal analysis we additionally adjusted for time between
MRI-scans. We ran the same analyses, with brain tissue volumes,
WMH volume, and FA and MD unstandardized (while adjusting
for intracranial volume in the regression model) to evaluate
clinical relevance of the associations. We compared our results
with previously reported brain tissue changes that ranged from
3.6 to 5.4ml (these values represent estimated average changes
over the head size distributions of the population studied) with 1
year of aging (12, 13).
We checked for interaction between body composition and
sex and between body composition and age (<60 vs. ≥60
years) as effects of BMI might differ between mid- and late-life
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(7). We were powered (alpha level: 0.05; power level: 0.80) to
detect minimal differences of 2.028ml brain tissue volume. A
p-value <0.05 was considered statistically significant. IBM SPSS
statistics version 24.0 (IBM Corp, Armonk, NY, USA) was used
for analyses.
RESULTS
Baseline characteristics are described in Table 1. Mean age was
65.9 years (standard deviation (SD): 9.8), 57.3%was female.Mean
BMI was 27.2 kg/m2 (SD: 3.9). Participants with a follow-upMRI
scan compared to those with only baseline MRI were younger,
higher educated, and healthier (Supplemental Table 1).
We found that cross-sectionally a higher BMI and FMI were
related with smaller white matter volumes (difference in Z-score
per SD higher BMI: −0.064 [95% CI: −0.094, −0.035]; FMI:
−0.067 [95% CI: −0.099, −0.034]), higher FA (BMI difference:
0.061 [95% CI: 0.031, 0.091]; FMI difference: 0.098 [95% CI:
0.065, 0.130]), and higher MD (BMI difference: 0.045 [95% CI:
0.018, 0.072]; FMI difference: 0.075 [95% CI: 0.045, 0.104]),
and a higher FFMI was related with larger gray matter volumes
(difference: 0.060 [95% CI: 0.018, 0.101]) (Table 2, model 1).
Effect estimates did not change between the different models
(Table 3, model 2), nor were there differences in effects of body
composition indices between the various outcomes of interest.
Though statistically significant, cross-sectional results might not
be clinically relevant as effect estimates of change in brain tissue
volumes, as well as their corresponding confidence intervals,
reported in milliliter difference per one point increase in BMI,
FMI, or FFMI are small and do not exceed clinically relevant
amounts of tissue changes (Supplemental Tables 2, 3).
Only the longitudinal association between FFMI and change
in hippocampus volume was statistically significant (difference:
−0.089 [95% CI: −0.151, −0.026]) (Table 2; model 1), and did
not change across models. However, it is questionable whether
the direction of this association is biological plausible, and when
reporting this association in milliliter (Supplemental Table 3;
model 2), it is borderline statistically significant (difference in
milliliter per one point increase in FFMI: −0.027 [95% CI:
−0.055, 0.000]). We did not find any statistically significant
or clinically relevant longitudinal associations between body
composition, brain tissue volumes, white matter integrity, or
markers of CSVD (Tables 2, 3; Supplemental Tables 2, 3). Both
cross-sectional and longitudinal results did not differ between
midlife and late life (data not shown), or between males and
females (Supplemental Table 4).
DISCUSSION
We found that detailed measures of body composition (higher
BMI and higher FMI) related to smaller white matter volume
and decreased white matter microstructure and that higher
FFMI related to higher gray matter volumes. However,
expressing those cross-sectional associations in milliliter
difference, raises the question whether those are also clinically
relevant. No statistically significant or clinically relevant
TABLE 1 | Population characteristics.
Characteristics Population for
cross-sectional
analysis
Population for
longitudinal analysis
Baseline N = 3,648 Baseline N = 1,844
Age, years 65.9 (11.1) 60.9 (9.9)
Age range, years 45.7–97.8 44.1–90.2
Female, % 57.3 55.9
Education level, %
Primary 8.1 7.1
Lower 38.5 35.4
Middle 30.1 29.3
Higher 22.4 27.9
Hypertension, % 44.1 34.3
Hypercholesterolemia, % 50.1 46.9
Diabetes, % 8.4 7.4
Smoking, %
Never 33.0 33.3
Former 52.1 49.7
Current 14.4 16.4
Physical activity, MET-hours
per week
44.7 (18.0–83.8)a 46.3 (19.6–83.8)a
Energy intake, kcal/day 2,090.5
(1,689.6–2,571.6)a
2,2567.0
(1,777.8–2,647.2)a
Alcohol intake, g/day 7.3 (1.1–17.6)a 8.5 (1.7–20.0)a
Body Composition
Length, cm 168.4 (9.4) 169.5 (9.4)
Weight, kg 77.4 (13.6) 77.9 (13.6)
Body mass index, kg/m2 27.2 (3.9) 27.0 (3.8)
Fat mass index, kg/m2 9.6 (3.3) 9.3 (3.3)
Fat free mass index, kg/m2 17.6 (2.1) 17.4 (2.2)
Brain MRI Volumetry
Brain tissue volume, mL 930.2 (103.3) 949.4 (101.8)
Gray matter volume, mL 528.3 (60.8) 536.2 (61.9)
White matter volume, mL 401.8 (64.9) 413.2 (62.9)
Fractional anisotropy 0.3 (0.0) 0.3 (0.0)
Mean diffusivity 0.7 (0.0) 0.7 (0.0)
Markers of Cerebral Small
Vessel Disease
Lacunes, presence % 7.2 4.7
Microbleeds, presence % 19.7 16.1
White hyperintensity volume 8.2 (1.1)* 7.9 (1.0)*
MET, metabolic equivalent of task; kcal, kilocalories; g, gram; cm, centimeter; kg, kilogram;
m, meter; mL, milliliter. Values are mean (standard deviation) for continuous variables
or median (interquartile range) when indicated (a), percentages for dichotomous
variables. *ln-transformed.
associations were found longitudinally (median follow-up:
5.5 years).
Strengths of this study are the large sample size, the distinction
of body composition, the wide range of brain imaging markers,
and the longitudinal design. However, some limitations should
also be acknowledged. First, due to the observational design we
cannot exclude the possibility of residual confounding. Second,
we did not adjust for possible changes in body composition over
time in the longitudinal analysis.
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Previous studies showed that body composition relates
to brain structure (14, 15), which is replicated in some of
our cross-sectional results. Currently there are no established
thresholds for rates of brain atrophy. However, in two other
population-based studies, change in brain tissue volume
with 1 year of aging were found to range from 3.6 to 5.4ml
(12, 13). Against this background, it is questionable whether a
(cross-sectional) 0.496ml smaller brain volume per one-point
increase in BMI (independent of age) and other (longitudinal)
effect estimates, are also clinically relevant. The absence of a
longitudinal association did not result from insufficient power,
as we were able to minimally detect a change of 2.028ml
brain tissue volume, which is smaller than a clinically relevant
change of 5ml brain volume (12). Though, the absence of a
longitudinal association might result in part from selection bias.
Indeed, it appeared that participants with MRI at follow-up
compared to those without follow-up were younger, higher
educated, and healthier. Another explanation might be that
the effects of body composition in midlife and late life may be
reversed (7, 16). But, we could not confirm effect modification
by age in our study. Other longitudinal studies are inconclusive
in their results, both reporting non-significant associations,
and significant associations between body composition and
various brain measurements (3, 5, 16–18), probably due to
different methodologies. In a study investigating whether the
effect of obesity on the brain increased with age they found no
significant results and thus suggested that obesity may act as a
modifier of brain atrophy rather than it being a direct cause (19).
Cardiovascular risk factors (hypertension, glucose, cholesterol,
plasma triglyceride) are known to co-occur frequently with
obesity and have independent negative effects on brain structure
(2, 20–22). Therefore, although we did not find significant
associations between body composition and markers of CSVD,
it might be that the effects of vascular risk factors may be
less pronounced in their effects on brain structure. And it
might also be that solely body composition does not influence
brain health, but it is rather the interplay of cardiovascular
risk factors altogether that may impact brain health
negatively (23, 24).
Since BMI may not be a good approximation for body
composition (25), we used FMI and FFMI. Surprisingly,
both cross-sectionally and longitudinally, regression estimates
between the different body composition measurement (BMI,
FMI, and FFMI) and brain MRI data did not differ.
Based on our findings it seems that cross-sectional
associations between body composition and brain health
likely reflect cumulative risk or shared etiology. Moreover,
it seems that body composition, decomposed into fat mass,
and fat-free mass, does not influence brain changes or the
presence of CSVD. Therefore, we cannot conclude that FMI and
FFMI is a better approximation of adiposity than BMI to study
brain health. Other longitudinal studies are needed to replicate
our findings.
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